These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 11312040)
21. Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI. Hoffmann HD; Leibold E; Ehnes C; Fabian E; Landsiedel R; Gamer A; Poole A Toxicol Lett; 2010 Dec; 199(3):364-71. PubMed ID: 20933064 [TBL] [Abstract][Full Text] [Related]
22. Toluene diisocyanate and methylene diphenyl diisocyanate: asthmatic response and cross-reactivity in a mouse model. Pollaris L; Devos F; De Vooght V; Seys S; Nemery B; Hoet PH; Vanoirbeek JA Arch Toxicol; 2016 Jul; 90(7):1709-17. PubMed ID: 26468151 [TBL] [Abstract][Full Text] [Related]
23. Dermal exposure to toluene diisocyanate and respiratory cancer risk. Prueitt RL; Lynch HN; Zu K; Shi L; Goodman JE Environ Int; 2017 Dec; 109():181-192. PubMed ID: 28967432 [TBL] [Abstract][Full Text] [Related]
24. Immunization and challenge with toluene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways. Mapp CE; Lucchini RE; Miotto D; Chitano P; Jovine L; Saetta M; Maestrelli P; Springall DR; Polak J; Fabbri LM Am J Respir Crit Care Med; 1998 Jul; 158(1):263-9. PubMed ID: 9655739 [TBL] [Abstract][Full Text] [Related]
25. Toxicology of toluene diisocyanate. Collins MA Appl Occup Environ Hyg; 2002 Dec; 17(12):846-55. PubMed ID: 12495595 [TBL] [Abstract][Full Text] [Related]
26. Immunological effects of toluene diisocyanate exposure on painters. Huang J; Wang XP; Chen BM; Ueda A; Aoyama K; Matsushita T Arch Environ Contam Toxicol; 1991 Nov; 21(4):607-11. PubMed ID: 1662030 [TBL] [Abstract][Full Text] [Related]
27. Cellular and mediator profile in bronchoalveolar lavage of guinea pigs after toluene diisocyanate (TDI) exposure. Raulf M; Tennie L; Marczynski B; Potthast J; Marek W; Baur X Lung; 1995; 173(1):57-68. PubMed ID: 7776707 [TBL] [Abstract][Full Text] [Related]
28. A comparative respiratory sensitization study of 2,4- and 2,6-toluene diisocyanate using guinea pigs. Shiotsuka RN; Warren DL; Halliburton AT; Sturdivant DW Inhal Toxicol; 2000 Jul; 12(7):605-15. PubMed ID: 10880147 [TBL] [Abstract][Full Text] [Related]
29. Effect of simultaneous exposure to mixture of two skin sensitizers on skin sensitization response in guinea pigs and mice. Morimoto T; Higaki T; Ota M; Inawaka K; Kawamura S; Bungo T J Toxicol Sci; 2014 Feb; 39(1):163-71. PubMed ID: 24418720 [TBL] [Abstract][Full Text] [Related]
31. An asthma model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate. Sugawara Y; Okamoto Y; Sawahata T; Tanaka K Int Arch Allergy Immunol; 1993; 101(1):95-101. PubMed ID: 7684630 [TBL] [Abstract][Full Text] [Related]
32. TDI inhalation in guinea-pigs involves migration of dendritic cells. Ban M; Hettich D; Goutet M; Bonnet P Toxicol Lett; 1997 Dec; 93(2-3):185-94. PubMed ID: 9486955 [TBL] [Abstract][Full Text] [Related]
33. Airway hyperresponsiveness and inflammation induced by toluene diisocyanate in guinea pigs. Gordon T; Sheppard D; McDonald DM; Distefano S; Scypinski L Am Rev Respir Dis; 1985 Nov; 132(5):1106-12. PubMed ID: 2998244 [TBL] [Abstract][Full Text] [Related]
34. TDI can induce respiratory allergy with Th2-dominated response in mice. Ban M; Morel G; Langonné I; Huguet N; Pépin E; Binet S Toxicology; 2006 Jan; 218(1):39-47. PubMed ID: 16271432 [TBL] [Abstract][Full Text] [Related]
35. Delayed-type asthmatic response induced by repeated intratracheal exposure to toluene-2,4-diisocyanate in guinea pigs. Nabe T; Yamauchi K; Shinjo Y; Niwa T; Imoto K; Koda A; Kohno S Int Arch Allergy Immunol; 2005 Jun; 137(2):115-24. PubMed ID: 15855793 [TBL] [Abstract][Full Text] [Related]
36. Micronuclei, hemoglobin adducts and respiratory tract irritation in mice after inhalation of toluene diisocyanate (TDI) and 4,4'-methylenediphenyl diisocyanate (MDI). Lindberg HK; Korpi A; Santonen T; Säkkinen K; Järvelä M; Tornaeus J; Ahonen N; Järventaus H; Pasanen AL; Rosenberg C; Norppa H Mutat Res; 2011 Jul; 723(1):1-10. PubMed ID: 21453781 [TBL] [Abstract][Full Text] [Related]
37. Expression kinetics of miRNA involved in dermal toluene 2,4-diisocyanate sensitization. Anderson SE; Beezhold K; Lukomska E; Richardson J; Long C; Anderson K; Franko J; Meade BJ; Beezhold DH J Immunotoxicol; 2014; 11(3):250-9. PubMed ID: 24063594 [TBL] [Abstract][Full Text] [Related]
38. Toluene diisocyanate-induced asthma without airway hyperresponsiveness. Mapp CE; Dal Vecchio L; Boschetto P; De Marzo N; Fabbri LM Eur J Respir Dis; 1986 Feb; 68(2):89-95. PubMed ID: 3009212 [TBL] [Abstract][Full Text] [Related]
39. Andrographolide prevented toluene diisocyanate-induced occupational asthma and aberrant airway E-cadherin distribution via p38 MAPK-dependent Nrf2 induction. Sulaiman I; Tan K; Mohtarrudin N; Lim JCW; Stanslas J Pulm Pharmacol Ther; 2018 Dec; 53():39-51. PubMed ID: 30244166 [TBL] [Abstract][Full Text] [Related]
40. Dose-response relationships for chemical sensitization from TDI and DNCB. Huang J; Wang XP; Chen BM; Zhou XJ; Matsushita T Bull Environ Contam Toxicol; 1993 Nov; 51(5):732-9. PubMed ID: 7694697 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]